Keck School Faculty

Anil Tulpule, MD
Anil Tulpule, MD
Associate Professor of Clinical Medicine
Medicine
1441 Eastlake Ave. Health Sciences Campus Los Angeles
Dr. Tulpule began his medical education and career in his native India before coming to Southern California on a fellowship in medical oncology at the Keck School of Medicine. After completion of his first USC fellowship, Dr. Tulpule was granted an additional fellowship in the Department of Hematology where he is currently holds an assistant professor appointment. Dr. Tulpule remains active in AIDS research, including a ten year affiliation with the government sponsored AIDS-Related Malignancy Working Group at the National Cancer Institute.

He has received over fifteen research grants on a number of hematology related subjects and his work has been published in many noted medical journals. Dr. Tulpule is a member of the LAC+USC Medical Center’s Internal Review Board and has a role in determining the ethical implications of the center’s research studies. His dedication to ethical practices also includes a membership of USC Norris Comprehensive Cancer Center’s Patient’s Rights Committee.

The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study Cancer. 2019 Jan 29. . View in PubMed

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma J Clin Oncol. 2017 Nov 01; 35(31):3538-3546. . View in PubMed

A prospective cohort study of patients with peripheral T-cell lymphoma in the United States Cancer. 2017 Apr 01; 123(7):1174-1183. . View in PubMed

Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States Clin Lymphoma Myeloma Leuk. 2017 04; 17(4):193-200. . View in PubMed

Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib J Oncol Pharm Pract. 2017 Jan 01; 1078155217745710. . View in PubMed

p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study Am J Clin Pathol. 2014 Apr; 141(4):593-604. . View in PubMed

Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047 J Clin Oncol. 2013 Jan 01; 31(1):58-64. . View in PubMed

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity Lancet Oncol. 2010 Dec; 11(12):1149-59. . View in PubMed

Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy Cancer. 2010 Aug 15; 116(16):3969-77. . View in PubMed

Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma Blood. 2010 Jul 15; 116(2):297-305. . View in PubMed

KSHV-induced notch components render endothelial and mural cell characteristics and cell survival Blood. 2010 Jan 28; 115(4):887-95. . View in PubMed

Bendamustine therapy in chronic lymphocytic leukemia Expert Opin Pharmacother. 2009 Jul; 10(10):1687-98. . View in PubMed

Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma J Clin Oncol. 2008 Sep 20; 26(27):4473-9. . View in PubMed

Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies Cancer. 2006 Oct 15; 107(8):1909-17. . View in PubMed

Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma Clin Lymphoma Myeloma. 2006 Jul; 7(1):59-64. . View in PubMed

Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy J Clin Oncol. 2006 Apr 10; 24(11):1712-9. . View in PubMed

Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy J Clin Oncol. 2005 Nov 20; 23(33):8477-82. . View in PubMed

Multidrug resistance in AIDS-related lymphoma Curr Opin Oncol. 2005 Sep; 17(5):466-8. . View in PubMed

AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy J Clin Oncol. 2005 Jul 01; 23(19):4430-8. . View in PubMed

Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team J Clin Oncol. 2005 Feb 10; 23(5):990-8. . View in PubMed

Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium Blood. 2005 Feb 01; 105(3):1310-8. . View in PubMed

Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response J Clin Oncol. 2004 Jul 01; 22(13):2662-70. . View in PubMed

Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study Invest New Drugs. 2004 Jan; 22(1):63-8. . View in PubMed

Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma Cancer. 2002 Jul 01; 95(1):147-54. . View in PubMed

Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection Cancer. 2002 Mar 01; 94(5):1500-6. . View in PubMed

Multidrug resistance (MDR-1) expression in AIDS-related lymphomas Leuk Res. 2002 Feb; 26(2):121-7. . View in PubMed

Powered by SC CTSI
Go to Top